Ways to optimize the prediction of fatal and nonfatal cases of stroke in patients with peripheral atherosclerosis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Recently, there has been a significant increase in interest in research aimed at predicting cardiovascular risk in individuals with peripheral atherosclerosis. Aim: to study the effect of atherosclerotic lesions of various vascular basins on long-term prognosis and optimization of prediction of fatal and non-fatal cases of stroke in patients with peripheral atherosclerosis. Material and methods. The study included 519 patients with lesions of various vascular basins, who were treated in specialized departments. The average age of the examined patients was 60.0±8.7 years. Results. In the course of two-factor logistic regression analysis, we obtained a complex of factors that influence the risk of developing nonfatal cases of stroke, namely, «chronic ischemia of the lower limb + abdominal aorta» (p=0.043), «amputation of the lower limb in history + chronic ischemia of the lower limbs» (p=0.017). Conclusions. Original nomograms have been developed to assess the risk of stroke in patients with peripheral atherosclerosis.

Full Text

Restricted Access

About the authors

Natalia D. Kobzeva

Rostov State Medical University of the Ministry of Healthcare of Russia

Email: kobzeva.nataliya10gmail.com
PhD, assistant at the Department of internal diseases No. 1 Rostov-on-Don

Anatoly I. Martynov

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

MD, academician of RAS, professor of the Department of hospital therapy No. 1

Vladimir P. Terentiev

Rostov State Medical University of the Ministry of Healthcare of Russia

Email: vpterentev0mail.ru
MD, professor, head of the Department of internal diseases No. 1 Rostov-on-Don

References

  1. Бойцов С.А., Демкина А.Е., Ощепкова Е.В., Долгушева Ю.А. Достижения и проблемы практической кардиологии в России на современном этапе. Кардиология. 2019; 3: 53-59
  2. Kobzeva N., Terentiev V., Zolotukhina I. The use of statistical analysis methods in assessing long-term prognoses in patients with acute coronary syndrome and contrast-induced nephropathy. IOP Conference Series: Materials Science and Engineering. 2019; 680(1): 012011. https://dx.doi.org/10.1088/1757-899X/680/1/012011.
  3. Bonaca M.P., Gutierrez J.A., Creager M.A. et al. Acute limb ischemia and outcomes with vorapaxar in patients with peripheral artery disease: Results from the trial to assess the effects of vorapaxar in preventing heart attack and stroke in patients with atherosclerosis-thrombolysis in myocardial infarction. Circulation. 2016; 133(10): 997-1005. https://dx.doi.org/10.1161/CIRCULATIONAHA.115.019355.
  4. Madeira S., Rodrigues R., Tralhao A. et al. Assessment of perioperative mortality risk in patients with infective endocarditis undergoing cardiac surgery: Performance of the EuroSCORE I and II logistic models.Interact Cardiovasc Thorac Surg. 2016; 22(2): 141-48. https://dx.doi.org/10.1093/icvts/ivv304.
  5. Fearon W.F., Nishi T., De Bruyne B. et al. Clinical outcomes and costeffectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: Three-year follow-up of the FAME 2 trial (Fractional flow reserve versus Angiography for Multivessel Evaluation). Circulation. 2018; 137(5): 480-87. https://dx.doi.org/10.1161/CIRCULATIONAHA.117.031907.
  6. Zhang J., Dong Z., Liu P. et al. Different strategies in simultaneous coronary and carotid artery revascularization - a single center experience. Arch Iran Med. 2019; 22(3): 132-36.
  7. Кобзева Н.Д. Особенности влияния атеросклеротического поражения различных сосудистых бассейнов на риск развития фатальных и нефатальных событий в отдаленном периоде. Терапия. 2021; 8: 70-75
  8. Рекомендации ЕОК/ЕОСХ по диагностике и лечению заболеваний периферических артерий 2017. Российский кардиологический журнал. 2018; 8: 164-221
  9. Knuuti J., Wijns W., Saraste A. et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407-77. https://dx.doi.org/10.1093/eurheartj/ehz425.
  10. Gerhard-Herman M.D., Gornik H.L., Barrett C. et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017; 135(12): 686-725. https://dx.doi.org/10.1161/CIR.0000000000000470.
  11. Saha T., Naqvi S.Y., Ayah O.A. et al. Subclavian artery disease: Diagnosis and therapy. Am J Med. 2017; 130(4): 409-16. https://dx.doi.org/10.1016/j.amjmed.2016.12.027.
  12. Фенкель В.В., Шапошник И.И. Показатели эндотелиальной скорости сдвига в сонной артерии как маркер системного атеросклероза и сердечно-сосудистых заболеваний, обусловленных атеросклерозом. Кардиология. 2019; 5: 45-52
  13. Xing R., Moerman A.M., Ridwan Y. et al. Temporal and spatial changes in wall shear stress during atherosclerotic plaque progression in mice. R Soc Open Sci. 2018; 5(3): 171447. https://dx.doi.org/10.1098/rsos.171447.
  14. Maruhashi T., Soga J., Fujimura N. et al. Brachial artery diameter as a marker for cardiovascular risk assessment: FMD-J study. Atherosclerosis. 2018; 268: 92-98. https://dx.doi.org/10.1016/j.atherosclerosis.2017.11.022.
  15. Погосова Н.В., Юферева Ю.М., Качанова Н.П. с соавт. Разработка алгоритма диагностики доклинического атеросклероза у пациентов из группы высокого риска развития сердечно-сосудистых заболеваний. Кардиология. 2020; 2: 75-82.
  16. Губарева М.Ю., Малышев П.П., Аншелес А.А., Сергиенко И.В. Оценка факторов риска развития атеросклероза у лиц различных категорий риска развития сердечно-сосудистых заболеваний при использовании калькулятора Aterostop. Кардиология. 2021; 3: 12-17
  17. Kotseva K., De Backer G., De Bacquer D. et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019; 26(8): 824-35. https://dx.doi.org/10.1177/2047487318825350

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies